Home > Online Clinic News > Flibanserin

Latest News

by Robert MacKay, Friday, June 28, 2013 | Categories: Flibanserin

Sprout Pharmaceuticals has successfully sent Flibanserin to be reviewed by the Food and Drug Administration (FDA)...




by Robert MacKay, Friday, October 8, 2010 | Categories: Flibanserin

Flibanserin is no more...




by Robert MacKay, Monday, June 21, 2010 | Categories: Female Sexual Dysfunction | Flibanserin

As expected, the panel convened by the Federal Food and Drug Administration has voted against granting Boeringer Ingelheim’s Hypoactive Sexual Desire Disorder medication flibanserin approval...




by Robert MacKay, Friday, June 18, 2010 | Categories: Female Sexual Dysfunction | Flibanserin

The pharmaceutical industry is waiting eagerly for the FDA to take a vote on whether to approve the controversial new drug flibanserin, which is designed to treat Hypoactive Sexual Desire Disorder (HSDD) in women...




Boehringer Ingelheim has posted new late-stage data from their clinical trials into their libido-boosting drug Flibanserin, which they are currently waiting for the European Medicines Agency and the Food and Drugs Agency to approve...




Page 1 of 2 in the Flibanserin category Next Page
 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close